Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Development of high sodium renal hypertension during chronic blockade of the vascular effects of vasopressin.

Development of high sodium renal hypertension during chronic blockade of the vascular effects of vasopressin. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Development of high sodium renal hypertension during chronic blockade of the vascular effects of vasopressin. Abstract Text:

    Studies in sodium-dependent models of hypertension have shown that arginine-vasopressin (AVP) plays an important role in the maintenance of blood pressure, predominantly through its vasoconstrictor action. In addition to AVP, the sympathetic nervous system (SNS) also acts to maintain blood pressure in high sodium one-kidney, figure-8 renal wrap hypertension. The purpose of this study was to determine if chronic blockade of vascular AVP (V1) receptors affected the induction of high sodium renal hypertension and the contribution of the SNS to the maintenance of blood pressure. Rats receiving chronic s.c. administration of a V1 antagonist, d(CH2)5Tyr(Me)AVP, or vehicle were subjected to renal wrapping or sham surgery, V1 receptor blockade was confirmed periodically by an 80 +/- 3% reduction of the pressor response to a bolus injection of 10 mU/kg of AVP. d(CH2)5Tyr(Me)AVP did not affect the development of hypertension or the associated changes in plasma sodium, potassium, osmolality and hematocrit. In renal-wrapped rats, ganglionic blockade caused a greater fall in blood pressure in animals treated with d(CH2)5Tyr(Me)AVP than in vehicle-treated animals. However, this apparent increase in SNS function was not responsible for the hypertension in d(CH2)5Tyr(Me)AVP-treated, renal-wrapped rats, inasmuch as ganglionic blockade lowered blood pressure a similar amount in normotensive d(CH2)5Tyr(Me)AVP-treated, sham-operated rats and blood pressure remained elevated after combined blockade of the SNS, AVP and the renin-angiotensin systems. These results indicated that chronic blockade of V1 receptors did not alter the induction of high sodium renal hypertension and the mechanism of the elevated blood pressure was not through an activation of the SNS or other neurohumoral mechanisms.

    Development of high sodium renal hypertension during chronic blockade of the vascular effects of vasopressin. Publishing Authors By Initials

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Development of high sodium renal hypertension during chronic blockade of the vascular effects of vasopressin. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: The Journal of pharmacology and experimental thera

    VOLUME: 238

    Page Numbers: 492-6

    Journal Abbreviation: J. Pharmacol. Exp. Ther.

    ISSN: 0022-3565

    DAY: 16

    MONTH: Aug

    YEAR: 1986

    Development of high sodium renal hypertension during chronic blockade of the vascular effects of vasopressin. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 376362

    Development of high sodium renal hypertension during chronic blockade of the vascular effects of vasopressin. Keywords Mesh Terms:

    KEYWORDS: Sodium

    MESH TERMS: blood

    Chemical & Substance for Abstract: Development of high sodium renal hypertension during chronic blockade of the vascular effects of vasopressin. Information

    Substance Name: Sodium

    Registry Number: 7440-23-5

    Grant and Affiliation Information for Development of high sodium renal hypertension during chronic blockade of the vascular effects of vasopressin.

    AFFILIATION:

    Country: UNITED STATES

    UNITED STATES Research PublicationUNITED STATES Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: J Pharmacol Exp Ther

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Development of high sodium renal hypertension during chronic blockade of the vascular effects of vasopressin Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News